Home
Conditions
Lymphoma, B-Cell

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

508 public trials 143 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Recruiting

Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)

NCT06954805

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Stanford Medical Center Stanford, California, United States

Columbia University Irving Medical Center New York, United States

View Trial Details

Recruiting

A Cognitive Training Intervention for Improving Cognitive and Neurological Outcomes in Patients Undergoing Treatment for Relapsed or Refractory Multiple Myeloma or B-cell Non-Hodgkin Lymphoma

NCT07609030

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +20 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Recruiting

A Phase 1 Study of JV-213 Autologous CD79b-targeting Chimeric Antigen Receptor T-cell Therapy in Adults With Relapsed or Refractory B-cell Lymphomas

NCT05773040

Conditions: B-Cell Lymphomas, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: The University of Texas M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Evaluating the Safety and Efficacy of DuoCAR20.19.22-D95 in Adult Patients With Relapsed or Refractory B-cell Malignancies

NCT06879340

Conditions: B-Cell Non-Hodgkin Lymphoma, B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, +16 more
Locations: University of Kansas Cancer Center Westwood, Kansas, United States

View Trial Details

Recruiting

Efficacy and Safety of CD19-CAR.p40-T in Patients With Relapsed/Refractory CD19-Positive Hematologic Malignancies

NCT07584889

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, B Cell Lymphoma, +16 more
Locations: Shenzhen University General Hospital Shenzhen, Other (Non U.s.), China

View Trial Details

Recruiting

Clinical Study of U01（ssCART-19） in Patients With B-Cell Lymphoma

NCT07093073

Conditions: B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Tongji Hospital of Tongji University Shanghai, China

View Trial Details

Recruiting

Safety and Efficacy Study of Zamtocabtagene Autoleucel (MB-CART2019.1) in Pediatric Patients With R/R B-Cell Neoplasms

NCT06508931

Conditions: B-Cell Neoplasm, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Hôpital Robert Debré Paris, Boulevard Sérurier 48, France

Institut Gustave Roussy Villejuif, France

Universitaetsklinikum Muenster (UKM) - Klinik fuer Kinder- und Jugendmedizin - Paediatrische Haematologie und Onkologie Münster, Albert-Schweitzer-Campus 1, Gebaeude A1, Germany

IRCCS Ospedale Pediatrico Bambino Gesù Rome, Piazza Sant Onofrio 4, Italy

View Trial Details

Recruiting

Study of Relapsed/ Refractory B-cell Non- Hodgkin Lymphoma

NCT07125872

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Dr. Jackie Thomson Inc Johannesburg, South Africa

Albert Cellular Therapy Pretoria, South Africa

View Trial Details

Recruiting

Trial of ONC-PluReceptor NK Cells With Epcoritamab and Tafasitamab for Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma

NCT07283679

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

A Clinical Study Exploring the Safety, Efficacy and Metabolic Kinetics of CT1182 Injection in Patients With Relapsed / Refractory Non Hodgkin Lymphoma

NCT07548697

Conditions: B-cell Non Hodgkin Lymphoma (NHL), DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, +14 more
Locations: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Lymphoma, B-Cell

Lymphoma, B-Cell trial results

Related conditions